应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03759 康龙化成
重阳节翌日休市 10-16 16:08:16
26.400
-0.600
-2.22%
最高
28.280
最低
24.640
成交量
1,040万
今开
27.500
昨收
27.000
日振幅
13.48%
总市值
484.44亿
流通市值
94.51亿
总股本
18.35亿
成交额
2.73亿
换手率
2.90%
流通股本
3.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
10月19日康龙化成涨5.80%,中欧医疗健康混合A基金重仓该股
证券之星 · 16:35
10月19日康龙化成涨5.80%,中欧医疗健康混合A基金重仓该股
康龙化成涨5.80%,开源证券一个月前给出“买入”评级
证券之星 · 16:35
康龙化成涨5.80%,开源证券一个月前给出“买入”评级
康龙化成累计募资逾120亿元,实控人一致行动人两轮减持近8亿元
财中社 · 16:14
康龙化成累计募资逾120亿元,实控人一致行动人两轮减持近8亿元
午后突升,医疗ETF华宝、药ETF华宝携手走强!CXO强势反弹,康龙化成冲涨8%!中药股获追捧,达仁堂涨停封板
新浪基金 · 14:25
午后突升,医疗ETF华宝、药ETF华宝携手走强!CXO强势反弹,康龙化成冲涨8%!中药股获追捧,达仁堂涨停封板
康龙化成(300759)10月16日主力资金净卖出2.33亿元
证券之星 · 09:11
康龙化成(300759)10月16日主力资金净卖出2.33亿元
康龙化成(300759)披露股东询价转让结果暨权益变动提示性公告,10月16日股价下跌6.81%
证券之星 · 10-16
康龙化成(300759)披露股东询价转让结果暨权益变动提示性公告,10月16日股价下跌6.81%
异动解读|康龙化成盘中上涨3.33%,股东询价转让落地后抛压边际缓和
行情直击 · 10-16
异动解读|康龙化成盘中上涨3.33%,股东询价转让落地后抛压边际缓和
康龙化成(03759)实控人一致行动人完成1%股权询价转让 交易额约7.15亿元
公告速递 · 10-15
康龙化成(03759)实控人一致行动人完成1%股权询价转让 交易额约7.15亿元
康龙化成(03759)主要股东减持1% A股 套现约7.15亿元
公告速递 · 10-15
康龙化成(03759)主要股东减持1% A股 套现约7.15亿元
摩根士丹利在康龙化成的H股好仓比例上升0.15%至6.36%
南方财经网 · 10-15
摩根士丹利在康龙化成的H股好仓比例上升0.15%至6.36%
康龙化成(300759)披露将于10月27日审议2026年前三季度业绩,10月14日股价下跌1.48%
证券之星 · 10-14
康龙化成(300759)披露将于10月27日审议2026年前三季度业绩,10月14日股价下跌1.48%
异动解读|康龙化成盘中下跌3.23%,股东询价转让折价定价压制股价
行情直击 · 10-14
异动解读|康龙化成盘中下跌3.23%,股东询价转让折价定价压制股价
康龙化成(300759)10月13日主力资金净卖出1.60亿元
证券之星 · 10-14
康龙化成(300759)10月13日主力资金净卖出1.60亿元
摩根大通10月7日增持哔哩哔哩与百度,减持药明康德等四股
同花顺 · 10-13
摩根大通10月7日增持哔哩哔哩与百度,减持药明康德等四股
摩根大通在康龙化成的H股好仓比例下降1.19%至14.08%
南方财经网 · 10-13
摩根大通在康龙化成的H股好仓比例下降1.19%至14.08%
康龙化成的“前端优势”与“后端兑现”
蓝鲸财经 · 10-13
康龙化成的“前端优势”与“后端兑现”
康龙化成(03759)将于10月27日召开董事会审议2026年前三季度业绩
公告速递 · 10-13
康龙化成(03759)将于10月27日召开董事会审议2026年前三季度业绩
异动解读|康龙化成盘中下跌3.41%,股东询价转让初步定价38.89元
行情直击 · 10-13
异动解读|康龙化成盘中下跌3.41%,股东询价转让初步定价38.89元
康龙化成(03759)披露股东询价转让初步定价 每股38.89元拟转让1,837.3万股
公告速递 · 10-12
康龙化成(03759)披露股东询价转让初步定价 每股38.89元拟转让1,837.3万股
康龙化成(300759)披露股东询价转让计划,10月12日股价下跌3.04%
证券之星 · 10-12
康龙化成(300759)披露股东询价转让计划,10月12日股价下跌3.04%
加载更多
公司概况
公司名称:
康龙化成
所属市场:
SEHK
上市日期:
--
主营业务:
康龙化成(北京)新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务,服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。
发行价格:
--
{"stockData":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":26.4,"timestamp":1792138096008,"preClose":27,"halted":0,"volume":10399297,"delay":0,"changeRate":-0.022222222222222275,"floatShares":358000000,"shares":1835000000,"eps":0.9393,"marketStatus":"重阳节翌日休市","change":-0.6,"latestTime":"10-16 16:08:16","open":27.5,"high":28.28,"low":24.64,"amount":273465253,"amplitude":0.134815,"askPrice":26.42,"askSize":5600,"bidPrice":26.4,"bidSize":13600,"shortable":3,"etf":0,"ttmEps":1.097374,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1574870400000,"exchange":"SEHK","adjPreClose":27,"dividendRate":0.008701,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":1.2778011183587408,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":38.5,"timestamp":1792393200000,"preClose":36.39,"halted":0,"volume":54233600,"delay":0,"premium":"-41.63"}},"requestUrl":"/m/hq/s/03759","defaultTab":"news","newsList":[{"id":"2676107509","title":"10月19日康龙化成涨5.80%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676107509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676107509?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:35","pubTimestamp":1792398910,"startTime":"0","endTime":"0","summary":"证券之星消息,10月19日康龙化成涨5.80%,收盘报38.5元,换手率3.82%,成交量54.23万手,成交额20.17亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共86家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","03759","BK1141","BK0216","BK1576","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509103","title":"康龙化成涨5.80%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509103?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:35","pubTimestamp":1792398903,"startTime":"0","endTime":"0","summary":"今日康龙化成涨5.80%,收盘报38.5元。2026年8月24日,开源证券研究员余汝意发布了对康龙化成的研报《公司信息更新报告:新签订单高增,CDMO加速兑现》,该研报对康龙化成给出“买入”评级。研报中预计2026-2028年公司归母净利润为22.13/29.34/37.65亿元,EPS为1.20/1.60/2.05元,当前股价对应PE为39.8/30.0/23.4倍,维持“买入”评级。康龙化成个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","161027","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509381","title":"康龙化成累计募资逾120亿元,实控人一致行动人两轮减持近8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509381","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509381?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:14","pubTimestamp":1792397640,"startTime":"0","endTime":"0","summary":"2026年6月11日,康龙化成(300759)A股收于21.58元/股,录得年内收盘低点;此后两个多月股价持续上行,至8月18日收于51.15元/股,创年内收盘新高,较低点累计上涨逾131%。8月21日,公司披露半年报的当日,A股收跌5.74%,报47.98元/股。国庆假期后,康龙化成股价自10月8日起连续七个交易日下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610193899913245.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610193899913245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","BK1576","BK1141","300759","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676508415","title":"午后突升,医疗ETF华宝、药ETF华宝携手走强!CXO强势反弹,康龙化成冲涨8%!中药股获追捧,达仁堂涨停封板","url":"https://stock-news.laohu8.com/highlight/detail?id=2676508415","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676508415?lang=zh_cn&edition=full","pubTime":"2026-10-19 14:25","pubTimestamp":1792391100,"startTime":"0","endTime":"0","summary":"CXO龙头领涨,康龙化成涨超8%,凯莱英涨超4%;医械股同步活跃,新产业涨近6%。制药板块午后亦启动,中药股强势,达仁堂涨停封板!分析指出,本次征求意见稿较草案口径收窄,创新药授权出海不受限制,且对CXO企业经营无影响,持续看好中国创新药及产业链在全球范围内影响力提升,行业景气度维持上行。药ETF华宝及其联接基金、医疗ETF华宝的风险等级为R3-中风险,适宜平衡型及以上的投资者。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-19/doc-inivtuen0898075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0164","BK0028","BK1576","BK0188","BK0060","CXO","562050","BK0239","BK0216","03759","512170","600329","BK1141","WX","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676571838","title":"康龙化成(300759)10月16日主力资金净卖出2.33亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676571838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676571838?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:11","pubTimestamp":1792372309,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月16日收盘,康龙化成报收于36.39元,下跌6.81%,换手率4.18%,成交量59.31万手,成交额22.51亿元。10月16日的资金流向数据方面,主力资金净流出2.33亿元,占总成交额10.37%,游资资金净流入7531.11万元,占总成交额3.35%,散户资金净流入1.58亿元,占总成交额7.03%。融券方面,融券卖出7200.0股,融券偿还1.49万股,融券余量11.38万股,融券余额414.3万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","BK1141","300759","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560741","title":"康龙化成(300759)披露股东询价转让结果暨权益变动提示性公告,10月16日股价下跌6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560741","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560741?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:23","pubTimestamp":1792142601,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘,康龙化成报收于36.39元,较前一交易日下跌6.81%,最新总市值为668.59亿元。公司于近日披露《股东询价转让结果报告书暨股东权益变动触及1%整数倍的提示性公告》。本次转让后,公司实际控制人及其一致行动人合计持股比例由17.60%下降至16.52%。转让方式为向特定机构投资者询价转让,不涉及集中竞价交易,受让方所获股份6个月内不得转让。本次权益变动未导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600029284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","BK0216","BK1576","BK1141","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146260790","title":"异动解读|康龙化成盘中上涨3.33%,股东询价转让落地后抛压边际缓和","url":"https://stock-news.laohu8.com/highlight/detail?id=1146260790","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146260790?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:35","pubTimestamp":1792114510,"startTime":"0","endTime":"0","summary":"10月16日,康龙化成盘中上涨3.33%,报27.94港元,成交额624.18万港元。此次转让此前获3.32倍认购,受让股份6个月内不得转让。交易完成后,Pharmaron Holdings持股比例由9.82%降至8.82%,三名实际控制人合计持股比例由17.52%降至16.52%,公司第一大股东及实际控制人未发生变化。此前折价定价曾压制股价,转让结果正式落地后,市场对不确定性的消化有所推进。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康龙化成盘中上涨,股东转让落地抛压缓和","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136531460","title":"康龙化成(03759)实控人一致行动人完成1%股权询价转让 交易额约7.15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136531460","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136531460?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:20","pubTimestamp":1792063254,"startTime":"0","endTime":"0","summary":"2026年10月15日,康龙化成(北京)新药技术股份有限公司(股票代码:03759)发布公告称,其实际控制人一致行动人Pharmaron Holdings Limited已通过向特定机构投资者询价转让方式完成1.00%股份(18,373,000股)的转让,成交价为38.89元/股,对应交易金额7.15亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148540848","title":"康龙化成(03759)主要股东减持1% A股 套现约7.15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148540848","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148540848?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:15","pubTimestamp":1792062928,"startTime":"0","endTime":"0","summary":"康龙化成(北京)新药技术股份有限公司10月15日公告披露,主要股东Pharmaron Holdings Limited已通过询价转让方式向13家机构投资者合计出售18,373,000股A股,占公司当日已发行股本总额约1.00%。本次转让价格为每股人民币38.89元,对应交易总金额人民币714,525,970元,折合约7.15亿元。减持完成后,Pharmaron Holdings Limited的持股数量由180,496,500股A股降至162,123,500股A股,其持股比例由9.82%降至8.82%。交易完成前,三名实际控制人合计持有公司321,883,550股A股,占比17.52%;交易完成后,合计持股降至303,510,550股A股,占比16.52%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675300724","title":"摩根士丹利在康龙化成的H股好仓比例上升0.15%至6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675300724","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675300724?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:18","pubTimestamp":1792055880,"startTime":"0","endTime":"0","summary":"南财智讯10月15日电,香港交易所披露信息显示,MorganStanley(摩根士丹利)在康龙化成的H股好仓(L)比例于10月9日从6.21%上升至6.36%。同时淡仓(S)比例从3.99%升至4.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610153896992950.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610153896992950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK0216","300759","03759","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675317449","title":"康龙化成(300759)披露将于10月27日审议2026年前三季度业绩,10月14日股价下跌1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675317449","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675317449?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:22","pubTimestamp":1791969778,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘,康龙化成报收于40.0元,较前一交易日下跌1.48%,最新总市值为734.91亿元。该股当日开盘40.88元,最高41.12元,最低39.87元,成交额达10.09亿元,换手率为1.76%。近日,康龙化成(北京)新药技术股份有限公司董事会宣布,将于2026年10月27日举行董事会会议,审议及批准本公司及其附属公司截至2026年9月30日止九个月之第三季度业绩及其发布。本次会议由董事长楼柏良博士签署公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400029038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","BK0216","300759","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179137856","title":"异动解读|康龙化成盘中下跌3.23%,股东询价转让折价定价压制股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1179137856","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179137856?lang=zh_cn&edition=full","pubTime":"2026-10-14 14:05","pubTimestamp":1791957939,"startTime":"0","endTime":"0","summary":"10月14日,康龙化成盘中下跌3.23%,报27.6港元,成交额1.69亿港元。消息面上,公司股东Pharmaron Holdings Limited此前将1.00%股份询价转让初步定价为38.89元/股,较10月12日A股收盘价折价约6.96%,拟转让1837.3万股并获3.32倍认购、由13家机构全额认购,受让股份6个月内不得转让。此外,摩根大通于10月7日将公司H股好仓比例由15.27%降至14.08%。公司将于10月27日召开董事会审议前三季度业绩。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康龙化成遭股东折价转让,股价承压下行","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399514","title":"康龙化成(300759)10月13日主力资金净卖出1.60亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399514?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:13","pubTimestamp":1791940396,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,康龙化成报收于40.6元,下跌2.87%,换手率3.59%,成交量50.96万手,成交额20.37亿元。10月13日的资金流向数据方面,主力资金净流出1.6亿元,占总成交额7.84%,游资资金净流出1.96亿元,占总成交额9.63%,散户资金净流入3.56亿元,占总成交额17.48%。融券方面,融券卖出2600.0股,融券偿还4.66万股,融券余量13.26万股,融券余额538.15万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","BK0216","03759","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675581913","title":"摩根大通10月7日增持哔哩哔哩与百度,减持药明康德等四股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675581913","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675581913?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:56","pubTimestamp":1791885360,"startTime":"0","endTime":"0","summary":"10月13日,香港交易所(00388.HK)信息显示,摩根大通于10月07日对多只港股H股持股比例发生变动。增持方面:摩根大通在哔哩哔哩-WH股的持股比例从19.05%升至19.80%;在百度集团-SWH股的持股比 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261013/c680647197.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261013/c680647197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688235","LU0348735423.USD","BK1618","LU0588546209.SGD","LU1719994722.HKD","BK1587","SG9999002463.SGD","HK0000306701.USD","LU0072913022.USD","LU1008478684.HKD","LU0359202008.SGD","LU2328871848.SGD","SG9999002828.SGD","LU0228659784.USD","HK0000306685.HKD","LU0823426308.USD","LU1048596156.SGD","LU0320764599.SGD","LU0359201612.USD","BK1141","LU0287142896.SGD","IE00B3M56506.USD","SG9999006597.SGD","LU0880133367.SGD","LU1048588211.SGD","603259","TCHI","LU0762542818.HKD","LU0417516902.SGD","LU0531971595.HKD","LU0307460666.USD","LU0229945570.USD","LU2097828557.USD","LU0762540952.USD","09888","SG9999001069.SGD","BK1163","BK1608","LU1831875114.USD","LU1046422090.SGD","SG9999014674.SGD","300759","LU0819121731.USD","LU0067412154.USD","LU0348825331.USD","LU2045819591.USD","BIDU","BILI","LU0501845795.SGD","LU2097828714.EUR","688008","LU0469268626.HKD","LU1481107354.HKD","LU0823426480.USD","06809","SG9999003461.SGD","LU1328615791.USD","LU2097828805.USD","BK1588","LU0463099449.HKD","LU2097828631.EUR","03759","BK1500","06160","LU1303224171.USD","LU1251922891.USD","LU0856984785.SGD","02359","LU0197773160.USD","KURE","LU0831093199.SGD","LU0871576103.HKD","LU1807302812.USD","LU0043850808.USD","LU1152091168.USD","LU0051755006.USD","LU0197773673.USD","LU0228367735.SGD","BK1104","LU0543330566.HKD","LU0326950275.SGD","SG9999001093.SGD","LU1152091754.HKD","LU0163747925.USD","HK0000320223.HKD","LU0630378429.USD","BK1609","LU0072462343.USD","LU0173614495.USD","SG9999001051.SGD","LU0244354667.USD","LU0052750758.USD","LU1115378108.SGD","LU0572944931.SGD","LU0315179316.USD","LU2125910500.SGD","IE0034224299.USD","LU0828237510.HKD","LU2778985437.USD","89888","LU0630378692.HKD","LU0348767384.USD","LU2242644610.SGD","09626","LU1188198961.HKD","LU0164865239.USD","LU0417516738.SGD","LU0348766576.USD","HK0000320264.USD","LU1206782309.USD","LU0708995583.HKD","BK1583","LU0164880469.USD","LU0039217434.USD","LU1993786604.SGD","LU0456827905.SGD","BK1576","LU1969619763.USD","BK1575","BK1095","LU0149721374.USD","LU0821914370.USD","LU2039709279.SGD","LU1770034418.SGD","ONC","LU1023057109.AUD","LU1960683339.HKD","LU0640798160.USD","BK1615","BK1161","LU0327786744.USD","LU2097828474.EUR","LU2476274308.USD","LU0359201885.HKD","LU0762541174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675920330","title":"摩根大通在康龙化成的H股好仓比例下降1.19%至14.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675920330","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675920330?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:20","pubTimestamp":1791883200,"startTime":"0","endTime":"0","summary":"南财智讯10月13日电,香港交易所披露信息显示,JPMorganChase&Co.(摩根大通)在康龙化成的H股好仓(L)比例于10月7日从15.27%下降至14.08%。同时淡仓(S)比例从3.83%降至3.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610133894225565.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610133894225565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300759","PGF","03759","BK0216","BK4582","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675334498","title":"康龙化成的“前端优势”与“后端兑现”","url":"https://stock-news.laohu8.com/highlight/detail?id=2675334498","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675334498?lang=zh_cn&edition=full","pubTime":"2026-10-13 16:39","pubTimestamp":1791880798,"startTime":"0","endTime":"0","summary":"文|财华社康龙化成在国内CRDMO赛道中呈现前端强、后端追赶的平台特征。2026年上半年,康龙化成收入75.95亿元,同比增长17.92%;归母净利润7.50亿元,同比增长6.96%;经调整非会计准则归母净利润9.09亿元,同比增长20.29%。2026年上半年,康龙化成临床研究服务的毛利率仅9.77%,同比还下降了2.56个百分点,盈利表现偏弱。2026年上半年,康龙化成整体毛利率32.58%,其中CDMO服务毛利率25.56%;凯莱英同期的整体毛利率为41.99%,小分子CDMO业务毛利率高达47.41%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1791857869533228879","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1141","300759","BK0216","BK1576","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149772334","title":"康龙化成(03759)将于10月27日召开董事会审议2026年前三季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1149772334","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149772334?lang=zh_cn&edition=full","pubTime":"2026-10-13 16:35","pubTimestamp":1791880535,"startTime":"0","endTime":"0","summary":"康龙化成(北京)新药技术股份有限公司(股票代码:03759)10月13日发布公告称,公司董事会会议将于2026年10月27日(星期二)举行,届时将审议并批准公司及其附属公司截至2026年9月30日止九个月的第三季度业绩及其发布事宜。\n公告显示,参会的董事包括执行董事楼柏良博士、楼小强先生、郑北女士,职工代表董事李承宗先生,非执行董事万璇女士,以及独立非执行董事李丽华女士、曾劲峰教授和沈蓉女士。\n公司提醒投资者,董事会审议通过相关业绩后将对外披露,敬请关注后续公告。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164641301","title":"异动解读|康龙化成盘中下跌3.41%,股东询价转让初步定价38.89元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164641301","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164641301?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:38","pubTimestamp":1791855501,"startTime":"0","endTime":"0","summary":"10月13日,康龙化成盘中下跌3.41%,报29.36港元,成交额2020.45万港元。消息面上,公司于10月12日披露股东询价转让初步定价为38.89元/股,拟转让1837.3万股获全额认购,受让方为13家机构投资者。此次询价转让价格为38.89元/股,较10月12日A股收盘价41.8元折价约6.96%。出让方Pharmaron Holdings Limited为公司境外员工持股平台,转让原因为自身资金需求,受让股份在过户后6个月内不得转让。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康龙化成股价下跌,股东折价转让引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133029508","title":"康龙化成(03759)披露股东询价转让初步定价 每股38.89元拟转让1,837.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1133029508","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133029508?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:45","pubTimestamp":1791801950,"startTime":"0","endTime":"0","summary":"2026年10月12日,康龙化成(北京)新药技术股份有限公司披露股东询价转让定价情况。根据当日询价申购结果,转让方Pharmaron Holdings Limited初步确定的转让价格为38.89元/股。累计有效认购股份数量为61,000,000股,认购倍数为3.32倍。拟转让的18,373,000股股份已获全额认购,初步确定的受让方为13家机构投资者。受让股份在过户后6个月内不得转让。公司提示,本次披露的受让方及受让股数为初步结果,最终转让情况以中国证券登记结算有限责任公司深圳分公司办理结果为准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876158","title":"康龙化成(300759)披露股东询价转让计划,10月12日股价下跌3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876158","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876158?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:52","pubTimestamp":1791798729,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘,康龙化成报收于41.8元,较前一交易日下跌3.04%,最新总市值为767.98亿元。该股当日开盘43.28元,最高44.22元,最低41.8元,成交额达14.61亿元,换手率为2.41%。近日,康龙化成披露《股东询价转让计划书》。公告显示,公司股东Pharmaron Holdings Limited拟通过询价转让方式转让其所持公司18,373,000股股份,占公司总股本的1.00%。本次转让不会导致公司控制权变更,亦无其他未披露重大事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200024239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","BK0216","BK1141","BK1576","03759"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharmaron.com","stockEarnings":[{"period":"1week","weight":-0.1373},{"period":"1month","weight":-0.0928},{"period":"3month","weight":0.1379},{"period":"6month","weight":0.2582},{"period":"1year","weight":0.0888},{"period":"ytd","weight":0.3629}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康龙化成(北京)新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务,服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.020006},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034007},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.039454},{"month":4,"riseRate":0.857143,"avgChangeRate":0.052246},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.006682},{"month":6,"riseRate":0.714286,"avgChangeRate":0.071007},{"month":7,"riseRate":0.714286,"avgChangeRate":0.108056},{"month":8,"riseRate":0.428571,"avgChangeRate":0.003953},{"month":9,"riseRate":0.714286,"avgChangeRate":0.134481},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.069867},{"month":11,"riseRate":0.333333,"avgChangeRate":0.036146},{"month":12,"riseRate":0.571429,"avgChangeRate":0.025859}],"exchange":"SEHK","name":"康龙化成","nameEN":"PHARMARON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,03759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}